Key Points- Novo Nordisk CEO Mike Doustdar said 2026 will be the year of “price pressure” as more GLP-1 supply enters the market and pricing deals take effect.- Bristol Myers Squibb CEO Chris Boerner said the company has the potential to deliver up to 10 new products by the end of the decade.- Pfizer CEO […]
